Sputnik

Swedish company ZandCell offers Russia 750 million dose vaccine capacity for Sputnik V and Aurora

Retrieved on: 
Thursday, July 29, 2021
COVID-19 pandemic in Russia, COVID-19 vaccines, Clinical trials, Medicine, Gamaleya Research Institute of Epidemiology and Microbiology, Science and technology in Russia, Vaccination, Sputnik V COVID-19 vaccine, Mass media, Sputnik, COVID-19 vaccine, COVID-19 vaccination in India

"We want either Sputnik V vaccine from Gamaleya or Aurora from Vector Institute.

Key Points: 
  • "We want either Sputnik V vaccine from Gamaleya or Aurora from Vector Institute.
  • I believe Sputnik V is the best vaccine in the world right now.
  • We are ready to manufacture 750 million doses per year and we offer our capacity to Russia.
  • For more information on ZandCell email: [email protected]
    Please visit the company's website at ZandCell.com or follow @ZandCell on Twitter.

Pandemic fight, economy among China topics of interest in survey

Retrieved on: 
Friday, July 2, 2021
Mass media, Television, State media, Sputnik, Chinese Communist Party, RT

The survey serves as a barometer of how people worldwide view China.

Key Points: 
  • The survey serves as a barometer of how people worldwide view China.
  • It asked them to choose the China-related topics they are most interested in.
  • As this year marks the 100th anniversary of the founding of the Communist Party of China, how the CPC works was also another topic of interest.
  • Victoria Polikarpova from Russia's Sputnik News Agency expected China to finance plans to deepen economic reforms, with a focus on research.

RDIF: Turkey becomes the 63rd country in the world to authorize Sputnik V

Retrieved on: 
Friday, April 30, 2021
COVID-19 pandemic in Russia, Adenoviridae, COVID-19 vaccines, Clinical trials, Sputnik V COVID-19 vaccine, Articles, Medicine, Life sciences, COVID-19 vaccine, Vaccination, Sputnik, COVID-19 vaccination in Russia

Turkey has become the 63rd country to authorize the use of Sputnik V. Total population of the countries where Sputnik V is approved for use exceeds 3.2 billion people.\nPost-vaccination studies in a number of countries demonstrate that SputnikV is the safest and most effective vaccine against coronavirus.

Key Points: 
  • Turkey has become the 63rd country to authorize the use of Sputnik V. Total population of the countries where Sputnik V is approved for use exceeds 3.2 billion people.\nPost-vaccination studies in a number of countries demonstrate that SputnikV is the safest and most effective vaccine against coronavirus.
  • Sputnik V ranks second among coronavirus vaccines globally in terms of the number of approvals issued by government regulators.\nRDIF had earlier reached an agreement with Turkey\'s Viscoran la pharmaceutical company to cooperate on production of Sputnik V in the country.
  • RDIF portfolio companies employ more than 800,000 people and generate revenues which equate to more than 6% of Russia\'s GDP.
  • RDIF has established joint strategic partnerships with leading international co-investors from more than 18 countries that total more than $40 bn.

RDIF: Turkey becomes the 63rd country in the world to authorize Sputnik V

Retrieved on: 
Friday, April 30, 2021
COVID-19 pandemic in Russia, Adenoviridae, COVID-19 vaccines, Clinical trials, Sputnik V COVID-19 vaccine, Articles, Medicine, Life sciences, COVID-19 vaccine, Vaccination, Sputnik, COVID-19 vaccination in Russia

Turkey has become the 63rd country to authorize the use of Sputnik V. Total population of the countries where Sputnik V is approved for use exceeds 3.2 billion people.\nPost-vaccination studies in a number of countries demonstrate that SputnikV is the safest and most effective vaccine against coronavirus.

Key Points: 
  • Turkey has become the 63rd country to authorize the use of Sputnik V. Total population of the countries where Sputnik V is approved for use exceeds 3.2 billion people.\nPost-vaccination studies in a number of countries demonstrate that SputnikV is the safest and most effective vaccine against coronavirus.
  • Sputnik V ranks second among coronavirus vaccines globally in terms of the number of approvals issued by government regulators.\nRDIF had earlier reached an agreement with Turkey\'s Viscoran la pharmaceutical company to cooperate on production of Sputnik V in the country.
  • RDIF portfolio companies employ more than 800,000 people and generate revenues which equate to more than 6% of Russia\'s GDP.
  • RDIF has established joint strategic partnerships with leading international co-investors from more than 18 countries that total more than $40 bn.

RDIF: Production of Sputnik V launched in Argentina

Retrieved on: 
Tuesday, April 20, 2021
COVID-19 pandemic in Russia, Science and technology in Russia, Sputnik V COVID-19 vaccine, Mass media, Kirill Dmitriev, Medicine, Articles, Russian Direct Investment Fund, Sputnik

"\nKirill Dmitriev, CEO of the Russian Direct Investment Fund, said:\n"Argentina was the first country of Latin America to approve Sputnik V and begin using it to vaccinate the population.

Key Points: 
  • "\nKirill Dmitriev, CEO of the Russian Direct Investment Fund, said:\n"Argentina was the first country of Latin America to approve Sputnik V and begin using it to vaccinate the population.
  • Today we are delighted to announce that Argentina has become the first country of the region to launch the production of Sputnik V thanks to parthership between RDIF and Laboratorios Richmond.
  • Sputnik V is approved in more than 10 countries of Latin and Central America and production in Argentina will help facilitate deliveries to other partners in the region.
  • "\n"Laboratories Richmond is proud to have the support of the Russian Direct Investment Fund that relied on our scientific and technical platform to produce the Sputnik V vaccine in Argentina.

RDIF thanks Mexico for seizing illegal shipment of fake Sputnik V vaccine

Retrieved on: 
Thursday, March 18, 2021
COVID-19 vaccines, Clinical trials, Adenoviridae, Medicine, Medical specialties, Mass media, COVID-19 pandemic in Russia, Science and technology in Russia, Sputnik V COVID-19 vaccine, Vaccine, Russian Direct Investment Fund, Sputnik

The shipment's procedure was also in violation of packaging and transportation protocols for the official Sputnik V vaccine.

Key Points: 
  • The shipment's procedure was also in violation of packaging and transportation protocols for the official Sputnik V vaccine.
  • RDIF states that every manufactured batch of Sputnik V vaccine is undergoing strict controls.
  • RDIF and Russian government entities will continue to cooperate with governments and partners around the world to jointly identify fake Sputnik V vaccines and ensure security of the Russian vaccine and its global supply chain.
  • Mexican government stopped and prevented this provocation possibly aimed at discrediting Sputnik V vaccine through shipment of fake vaccine.

Sputnik V registered in countries with total population of over 1.1 billion people

Retrieved on: 
Thursday, February 25, 2021
Finance, Money, Economy, Russian Direct Investment Fund, Kirill Dmitriev, Sputnik V COVID-19 vaccine, Sputnik, Sovereign wealth fund

MOSCOW, Feb. 25, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces that Sputnik V vaccine against coronavirus is now registered in 37 countries with total population of over 1.1 billion people.

Key Points: 
  • MOSCOW, Feb. 25, 2021 /PRNewswire/ -- The Russian Direct Investment Fund (RDIF, Russia's sovereign wealth fund) announces that Sputnik V vaccine against coronavirus is now registered in 37 countries with total population of over 1.1 billion people.
  • Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said:
    "An important milestone today: over 1.1 billion people live in 37 countries, where Sputnik V got emergency authorization.
  • The price of Sputnik V is less than $10 per shot, making it affordable around the world.
  • RDIF has established joint strategic partnerships with leading international co-investors from more than 18 countries that total more than $40 bn.

Dr. Reddy's Initiates Process for Emergency Use Authorization of Sputnik V

Retrieved on: 
Friday, February 19, 2021
Infectious diseases, Pharmaceutical, Health, Other Health, Clinical trials, Mass media, COVID-19 pandemic in Russia, Science and technology in Russia, Sputnik V COVID-19 vaccine, Health care, Medicine, Dr. Reddy's Laboratories, Sputnik, The Lancet

In September 2020, Dr. Reddys partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of the Sputnik V and for its distribution rights in India.

Key Points: 
  • In September 2020, Dr. Reddys partnered with the Russian Direct Investment Fund (RDIF) to conduct the clinical trials of the Sputnik V and for its distribution rights in India.
  • Sputnik V maintained a consistent efficacy at 91.8% even among the group of 2,144 volunteers over 60 years old.
  • G V Prasad, Co-chairman and Managing Director, Dr. Reddys Laboratories, said, The efficacy of Sputnik V was reported to be 91.6 % by the Lancet, which is an impressive development in the fight against COVID-19.
  • The initiation of the EUA process will be a critical step forward for us in ensuring speedy access to the Sputnik V vaccine in India.

Sputnik ATX, Austin-Based Venture Capital Fund and Accelerator, Selects Its Winter 2021 Cohort

Retrieved on: 
Thursday, February 4, 2021
Software, Mobile, Wireless, General Health, Online Retail, Professional services, Technology, Small business, Primary, Secondary, Education, Retail, Finance, Health, Mass media, Sputnik, State media, News media

Sputnik ATX, an Austin, Texas based venture capital fund and accelerator that backs early-stage founders solving big problems, announced the selection of its newest cohort for winter 2021.

Key Points: 
  • Sputnik ATX, an Austin, Texas based venture capital fund and accelerator that backs early-stage founders solving big problems, announced the selection of its newest cohort for winter 2021.
  • All of the companies selected tackle difficult problems and are changing their respective industries, consistent with Sputnik ATXs mission and culture.
  • Sputnik ATX, now in its fourth year, is clearly capitalizing on this opportunity, backed by its founding General Partners, Oksana Malysheva and Joe Merrill.
  • Sputnik ATX is a venture capital fund and accelerator in Austin, Texas that combines capital with training and mentorship focused on high growth and product-market fit.

Hungary becomes the first country in EU to authorize the Sputnik V vaccine

Retrieved on: 
Thursday, January 21, 2021
COVID-19 pandemic in Russia, Gam-COVID-Vac, Science and technology in Russia, Medicine, Mass media, Medical specialties, Kirill Dmitriev, Sputnik, Vaccine

Thus Hungary has become the first country in the European Union to authorize the use of Sputnik V. The vaccine was approved under the emergency use authorization procedure.

Key Points: 
  • Thus Hungary has become the first country in the European Union to authorize the use of Sputnik V. The vaccine was approved under the emergency use authorization procedure.
  • Sputnik V had been registered earlier under the same procedure in Algeria, Argentina, Bolivia, Serbia, Palestine, Venezuela, Paraguay and Turkmenistan.
  • Kirill Dmitriev, CEO of the Russian Direct Investment Fund, said:
    "Hungary is the first EU country to realize all the advantages of Sputnik V vaccine and authorize its use.
  • Sputnik V has a number of key advantages:
    Efficacy of Sputnik V is over 90%, with full protection against severe cases of COVID-19.